Welcome to LookChem.com Sign In|Join Free

CAS

  • or

98-79-3

Post Buying Request

98-79-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

98-79-3 Usage

Characteristics and Application

L-pyroglutamic acid is an amino acid that occurs naturally in the body. It is present in the brain, spinal fluid, skin and blood.pyroglutamic acid is one of the major components of natural moisturizing factor of the skin, its moisturizing ability is far stronger than glycerin and propylene glycol. Moreover, it is non-toxic, non-irritating, and is an excellent raw material for modern skin care, and hair care cosmetics. Pyroglutamic acid also has inhibitory effect on the tyrosine oxidase activity, and thus preventing "melanoidins" substance from being deposited in the skin, and having a whitening effect on the skin. It has a keratin softening effect which can be used in nail cosmetics.In addition to be applied in cosmetics, L-pyroglutamic acid derivatives can also have reaction with a number of other organic compounds for synthesis of derivatives. It also has some special effect on the surface activity and brilliant effect. Moreover, it can also be used as surfactants for detergents; as a chemical reagent, it can be used for the resolution of racemic amines; it can also be used as a kind of organic intermediates.

Pyroglutamic acid

Pyroglutamic acid is a kind of based 5-oxo-proline. It is produced by the dehydration and formation of intramolecular amide bond between the α-NH2 group and γ-hydroxy of glutamic acid; the molecule can also be produced from glutamine by losing its intramolecular amine group. The condition of glutathione synthetase deficiency can cause the anemia of pyroglutamic acid with a series of clinical symptoms. Pyroglutamic acid anemia is a kind of organic acid metabolic disorder disease caused by glutathione synthetase hyperlipidemia. Clinical manifestations: disease onset occurs within 12 to 24 hours of born with progressive hemolysis, jaundice, chronic metabolic acidosis, mental retardation; urine containing pyroglutamic acid, lactic acid, α-deoxy-4-hydroxyphenyl acetyl acid lactone. For treatment, based on the actual symptoms, pay attention to adjust the diet after yearling. The above information is edited by the lookchem of Dai Xiongfeng.

Preparation

L-pyroglutamic acid is formed by removing one intramolecular water molecule in the L-glutamic acid; the preparation process is simple with the key step being the control of the temperature and dehydration time. (1) Add100 g of L-glutamic acid into a 500-ml beaker; heat the beaker in an oil bath until the temperature was raised to 145~150 °C, incubate for 45 minutes to perform dehydration reaction. The dehydrated solution was brown. (2) After the end of dehydration reaction, pour the solution into a volume of about 350 ml of boiling water with a solution of all further being dissolved in water. Cool to 40~50 °C, add appropriate amount of activated carbon for decolorization (repeated twice) to obtain a colorless transparent solution. (3) directly heat and evaporate the colorless and transparent solution of the step (2) is a colorless and transparent solution for concentration to a half of the previous volume and then continue for concentration in a water bath to a volume of about 1/3 of the previous solution, and then stop heating; have it slightly cooled in the hot water bath for crystallization; the colorless prisms can be obtained after 10 to 20 hours. The applied amount of L-pyroglutamic acid in cosmetics should depend on the formula. This product can also be applied to cosmetic in the form of 50% concentrated solution.

Chemical Properties

Different sources of media describe the Chemical Properties of 98-79-3 differently. You can refer to the following data:
1. It is colorless crystals with the melting point being 162-163 °C; it is soluble in water, alcohol, acetone and acetic acid, slightly soluble in ethyl acetate, but insoluble in ether.
2. L-pyroglutamic acid has its scientific name being L-2-pyrrolidone-5-carboxylic acid. Precipitation from ethanol and petroleum ether mixture were colorless orthorhombic bipyramid crystals with the melting temperature being 162~163 °C. It is soluble in water, alcohol, acetone and acetic acid, slightly soluble in ethyl acetate, and insoluble in ether. Specific rotation-11.9 ° (c = 2, H2O). It is produced from 42% aqueous solution of glutamic acid which subjects to heating dehydration, concentration, crystallization, washing and drying to obtain L-pyroglutamic acid.

Uses

Different sources of media describe the Uses of 98-79-3 differently. You can refer to the following data:
1. L-Pyroglutamic acid is used in the synthesis of:Nonproteinogenic amino acids such as (3S,4R)-3,4-dimethyl-L-pyroglutamic acid and (3S,4R)-3,4-dimethyl-L-glutamine.Chiral N-heterocyclic carbenes (NHCs) as catalysts for the asymmetric dimerization of alkylarylketenes to give the corresponding α-quaternary β-alkylidenyl-β-lactones.It is also used in the total synthesis of (?)-stemoamide and celogentin C.It can be used as a kind of intermediates of organic synthesis as well as food additives.It is used in food, medicine, cosmetics and other industries.
2. L-Pyroglutamic acid is an amino acid that is used in the synthesis of peptides. It has also been observed to convert when placed at the N-terminus in vivo to create IgG2 antibodies.
3. A building block for pharmaceuticals and asymmetric synthesis
4. In the resolution of racemic amines.

Production method

There are semi-synthetic methods, enzymatic conversion method and total synthesis method. Currently the major approach of industrial production is the semi-synthetic method with glutamic acid being the raw material. Have the 42% of glutamic acid solution heated at 140 °C for 3h to obtain the reaction solution with L-pyroglutamic acid being the major component. The reaction solution further undergoes concentration under reduced pressure, crystallization, washing, and drying to obtain the L-pyroglutamic acid with the conversion rate being 94%.

Definition

ChEBI: An optically active form of 5-oxoproline having L-configuration.

Flammability and Explosibility

Notclassified

Purification Methods

Crystallise S-pyroglutamic acid by dissolving it in boiling EtOH (20g in 100mL), cooling and after a few minutes additing pet ether (b 40-60o, 120mL), then after 5 minutes adding a further 120mL, and coThis has m 155.5-157.5o and [] D -11.4o (c 4.4, H2O) [Hardy Synthesis 290 1978, Pellegata et al. Synthesis 614 1978]. The NH4 salt has m 184-186o (from EtOH). [Beilstein 22/6 V 7.]

Check Digit Verification of cas no

The CAS Registry Mumber 98-79-3 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 8 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 98-79:
(4*9)+(3*8)+(2*7)+(1*9)=83
83 % 10 = 3
So 98-79-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/p-1/t3-/m0/s1

98-79-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (P0573)  L-Pyroglutamic Acid  >97.0%(T)

  • 98-79-3

  • 25g

  • 230.00CNY

  • Detail
  • TCI America

  • (P0573)  L-Pyroglutamic Acid  >97.0%(T)

  • 98-79-3

  • 100g

  • 690.00CNY

  • Detail
  • TCI America

  • (P0573)  L-Pyroglutamic Acid  >97.0%(T)

  • 98-79-3

  • 500g

  • 2,420.00CNY

  • Detail
  • Alfa Aesar

  • (L11711)  (S)-(-)-2-Pyrrolidinone-5-carboxylic acid, 98+%   

  • 98-79-3

  • 25g

  • 117.0CNY

  • Detail
  • Alfa Aesar

  • (L11711)  (S)-(-)-2-Pyrrolidinone-5-carboxylic acid, 98+%   

  • 98-79-3

  • 100g

  • 323.0CNY

  • Detail
  • Alfa Aesar

  • (L11711)  (S)-(-)-2-Pyrrolidinone-5-carboxylic acid, 98+%   

  • 98-79-3

  • 500g

  • 1389.0CNY

  • Detail
  • Sigma

  • (P5960)    BioXtra

  • 98-79-3

  • P5960-25G

  • 549.90CNY

  • Detail
  • Sigma-Aldrich

  • (Y0000123)  Pidolicacid  European Pharmacopoeia (EP) Reference Standard

  • 98-79-3

  • Y0000123

  • 1,880.19CNY

  • Detail
  • Aldrich

  • (83160)  L-Pyroglutamicacid  ≥99.0% (T)

  • 98-79-3

  • 83160-25G

  • 208.26CNY

  • Detail
  • Aldrich

  • (83160)  L-Pyroglutamicacid  ≥99.0% (T)

  • 98-79-3

  • 83160-100G

  • 608.40CNY

  • Detail
  • Aldrich

  • (83160)  L-Pyroglutamicacid  ≥99.0% (T)

  • 98-79-3

  • 83160-500G

  • 2,354.04CNY

  • Detail

98-79-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-oxo-L-proline

1.2 Other means of identification

Product number -
Other names L-Pyroglutamicacid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:98-79-3 SDS

98-79-3Synthetic route

L-glutamic acid
56-86-0

L-glutamic acid

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With water for 16h; Heating;95%
In water for 16h; Heating;95%
With 1,1'-carbonyldiimidazole In chloroform at 55℃; for 3h; Solvent; Concentration;76.8%
L-N-t-butoxycarbonylpyroglutamic acid
53100-44-0

L-N-t-butoxycarbonylpyroglutamic acid

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With silica gel In dichloromethane for 0.0166667h; Irradiation;91%
With tin(II) trifluoromethanesulfonate In dichloromethane at 20℃; for 2h;87%
tert-butyl (S)-N-tert-butoxycarbonylpyroglutamate
91229-91-3

tert-butyl (S)-N-tert-butoxycarbonylpyroglutamate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane for 0.333333h; Ambient temperature;90%
L-glutamic acid γ-benzyl ester
1676-73-9

L-glutamic acid γ-benzyl ester

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide at 40℃; for 20h;88.3%
(5S)-2,2-bis(trifluoromethyl)-1-aza-3-oxabicyclo[3.3.0]octan-4,8-dione
317845-09-3

(5S)-2,2-bis(trifluoromethyl)-1-aza-3-oxabicyclo[3.3.0]octan-4,8-dione

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With water In isopropyl alcohol at 20℃;87%
L-glutamic acid
56-86-0

L-glutamic acid

A

Pyroglutamic acid
149-87-1

Pyroglutamic acid

B

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
at 175℃; under 3750.38 Torr; for 5h; Temperature; Pressure; Autoclave; Large scale;A 15.9%
B 83%
Boc-Gln-OH
13726-85-7

Boc-Gln-OH

trifluoroacetic acid
76-05-1

trifluoroacetic acid

A

L-glutamic acid
56-86-0

L-glutamic acid

B

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
at 20℃; for 0.25h;A 61%
B 18%
tert-butyl (4S,4'S,5'R)-4-amino-5-(3',4'-dimethyl-2'-oxo-5'-phenyl-1'-imidazolydinyl)-5-oxopentanoate
220280-79-5

tert-butyl (4S,4'S,5'R)-4-amino-5-(3',4'-dimethyl-2'-oxo-5'-phenyl-1'-imidazolydinyl)-5-oxopentanoate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With water for 12h; Hydrolysis; cyclization; Heating;45%
L-glutamic acid γ-benzyl ester
1676-73-9

L-glutamic acid γ-benzyl ester

A

benzaldehyde
100-52-7

benzaldehyde

B

benzoic acid
65-85-0

benzoic acid

C

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

D

benzyl alcohol
100-51-6

benzyl alcohol

Conditions
ConditionsYield
With sodium hydroxide; sodium tetrachloropalladate(II) In water Product distribution; Ambient temperature; initial pH:6.8; variation of initial pH and temperature;A 37%
B 4%
C n/a
D 24%
H-Glu(OChp)-OH
107930-17-6

H-Glu(OChp)-OH

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide at 40℃; for 20h;4.1%
D-Glutamic acid
6893-26-1

D-Glutamic acid

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With water
(S)-2-Amino-pentanedioic acid 5-ethyl ester
1119-33-1

(S)-2-Amino-pentanedioic acid 5-ethyl ester

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With ammonium hydroxide
diethyl 2-aminopentanedioate
55895-85-7

diethyl 2-aminopentanedioate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With water
L-glutamic acid diethyl ester
16450-41-2

L-glutamic acid diethyl ester

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With water
N-(benzyloxycarbonyl)-L-glutamic acid anhydride
4124-76-9

N-(benzyloxycarbonyl)-L-glutamic acid anhydride

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With palladium on activated charcoal; acetic acid Hydrogenation;
L-glutamine
56-85-9

L-glutamine

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
at 28℃; for 840h; pH=5.5 (acetate buffer), PhCH3 on surface;
With human blood serum at 24.84℃;
(S)-2-Amino-pentanedioic acid 5-ethyl ester
1119-33-1

(S)-2-Amino-pentanedioic acid 5-ethyl ester

A

ethanol
64-17-5

ethanol

B

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
In water at 40℃; Rate constant; pH 7.6-10.4, μ=0.5 (KCl);
histrelin
76712-82-8

histrelin

A

His-Trp-Ser-Tyr-(D-Nim-bzl-His)-Leu-Arg-Pro-NHEt
134190-11-7

His-Trp-Ser-Tyr-(D-Nim-bzl-His)-Leu-Arg-Pro-NHEt

B

cyclo(-His-Trp)

cyclo(-His-Trp)

C

Ser-Tyr-(D-Nim-bzl-His)-Leu-Arg-Pro-NHEt
134009-09-9

Ser-Tyr-(D-Nim-bzl-His)-Leu-Arg-Pro-NHEt

E

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With water at 87℃; for 432h; Product distribution; degradation, var. reaction time, temperature and ph;
N-Acetylpyroglutamic acid
53971-11-2

N-Acetylpyroglutamic acid

A

N-Acetyl-D-pyroglutamic acid
53971-11-2, 56805-18-6, 89885-76-7

N-Acetyl-D-pyroglutamic acid

B

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With potassium hydroxide; potassium phosphate buffer; porcine kidney acylase I at 40℃; relative initial rate of hydrolysis, also with Aspergillus acylase I as a catalyst;
ethyl (S)-pyroglutamate
7149-65-7

ethyl (S)-pyroglutamate

A

ethanol
64-17-5

ethanol

B

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With water In acetonitrile at 40℃; Rate constant; pH 9.7-10.5, μ=0.5 (KCl);
With 2-(di(2-hydroxyethyl)amino)ethanesulfonic acid; lipase from Bacillus thermocatenulanatus In water at 40℃; pH=7.20; Enzyme kinetics;
inactive form

inactive form

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
With Quinine
L-glutamic acid
56-86-0

L-glutamic acid

A

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

B

Fmoc-Pro-Rink amide-MBHA resin

Fmoc-Pro-Rink amide-MBHA resin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 67 percent / dimethylsulfoxide / 20 °C
2: 99 percent / SOCl2; DMF / CH2Cl2 / 20 °C
3: 87 percent / H2O / propan-2-ol / 20 °C
View Scheme
(S)-[2,2-bis(trifluoromethyl)-5-oxo-1,3-oxazolidin-4-yl]propionic acid
131021-88-0

(S)-[2,2-bis(trifluoromethyl)-5-oxo-1,3-oxazolidin-4-yl]propionic acid

A

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

B

Fmoc-Pro-Rink amide-MBHA resin

Fmoc-Pro-Rink amide-MBHA resin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 99 percent / SOCl2; DMF / CH2Cl2 / 20 °C
2: 87 percent / H2O / propan-2-ol / 20 °C
View Scheme
N-Boc-L-proline
15761-39-4

N-Boc-L-proline

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dicyclohexylcarbodiimide, 4-dimethylaminopyridine
2: 95 percent / RuO2 hydrate, 10percent aqueous NaIO4 / ethyl acetate / 2 h / Ambient temperature
3: 90 percent / CF3COOH / CH2Cl2 / 0.33 h / Ambient temperature
View Scheme
N-BOC-proline tert-butyl ester
91237-84-2

N-BOC-proline tert-butyl ester

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 95 percent / RuO2 hydrate, 10percent aqueous NaIO4 / ethyl acetate / 2 h / Ambient temperature
2: 90 percent / CF3COOH / CH2Cl2 / 0.33 h / Ambient temperature
View Scheme
Cbz-(L)-Glu-OBn
3705-42-8

Cbz-(L)-Glu-OBn

A

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

B

natrium carbonate

natrium carbonate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 75 percent / dicyclohexylcarbodiimide, 4-dimethylaminopyridine / tetrahydrofuran
2: 76 percent / H2, AcOH / Pd / methanol / 24 h
3: 4.1 percent / Et3N / dimethylformamide; H2O / 20 h / 40 °C
View Scheme
C26H48N6O15
1134188-65-0

C26H48N6O15

A

5-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-1-N-[(S)-4-amino-2-hydroxy-butanoyl]paromamine
1134188-60-5

5-O-(5-amino-5-deoxy-β-D-ribofuranosyl)-1-N-[(S)-4-amino-2-hydroxy-butanoyl]paromamine

B

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Conditions
ConditionsYield
BtrG enzyme In water at 20℃; for 24h; Product distribution / selectivity; HEPES buffer; Enzymatic reaction;
L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

methyl (S)-pyroglutamate
4931-66-2

methyl (S)-pyroglutamate

Conditions
ConditionsYield
In diethyl ether100%
With diethyl ether
In methanol; diethyl ether at 0℃; for 0.5h;
methanol
67-56-1

methanol

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

methyl (S)-pyroglutamate
4931-66-2

methyl (S)-pyroglutamate

Conditions
ConditionsYield
With thionyl chloride at 0 - 25℃;100%
With methanesulfonic acid In chloroform; water Reflux;100%
With Dowex-50W (X8-200) resin Inert atmosphere; Reflux;100%
acetic acid tert-butyl ester
540-88-5

acetic acid tert-butyl ester

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

L-t-butyl pyroglutamate
35418-16-7, 85136-12-5

L-t-butyl pyroglutamate

Conditions
ConditionsYield
With perchloric acid In water at 20℃; for 18h;100%
Stage #1: acetic acid tert-butyl ester; L-Pyroglutamic acid With perchloric acid at 20℃; for 48h; Inert atmosphere;
Stage #2: With perchloric acid for 48h; Inert atmosphere;
90%
With perchloric acid at 20℃; for 96h; Inert atmosphere;90%
1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

L-trimethylsilyl pyroglutamate
97717-45-8

L-trimethylsilyl pyroglutamate

Conditions
ConditionsYield
With saccharin for 2.5h; Heating;100%
benzyl chloride
100-44-7

benzyl chloride

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

benzyl (L)-pyroglutamate
94885-52-6

benzyl (L)-pyroglutamate

Conditions
ConditionsYield
With triethylamine In 1,2-dichloro-ethane at 60℃; for 15h; Temperature; Large scale;100%
With triethylamine In acetone for 168h; Heating;85%
With TEA In acetone85%
2-methyl-1-buten-4-ol
763-32-6

2-methyl-1-buten-4-ol

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(5S)-2-pyrrolidone-5-carboxylic acid 3-methyl-3-butenyl ester
865183-91-1

(5S)-2-pyrrolidone-5-carboxylic acid 3-methyl-3-butenyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃;100%
With dmap; dicyclohexyl-carbodiimide In dichloromethane
2-(Trimethylsilyl)ethanol
2916-68-9

2-(Trimethylsilyl)ethanol

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

2-(trimethylsilyl)ethyl (S)-5-oxopyrrolidine-2-carboxylate

2-(trimethylsilyl)ethyl (S)-5-oxopyrrolidine-2-carboxylate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene at 130℃; for 2h; Dean-Stark;100%
With toluene-4-sulfonic acid In benzene for 2h; Heating;
L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

pyroglutamoyl chloride
55478-53-0

pyroglutamoyl chloride

Conditions
ConditionsYield
Stage #1: L-Pyroglutamic acid With 1,1,1,3,3,3-hexamethyl-disilazane; saccharin for 2.5h; Heating / reflux;
Stage #2: With oxalyl dichloride In dichloromethane at 20℃; Heating / reflux;
100%
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(S)-toluene-4-sulfonic acid 5-oxo-pyrrolidin-2-ylmethyl ester
51693-17-5

(S)-toluene-4-sulfonic acid 5-oxo-pyrrolidin-2-ylmethyl ester

Conditions
ConditionsYield
Stage #1: L-Pyroglutamic acid With thionyl chloride In methanol at 20℃; for 4h;
Stage #2: With sodium tetrahydroborate In ethanol at 20℃; for 15h;
Stage #3: p-toluenesulfonyl chloride With dmap; triethylamine In dichloromethane at 20℃; for 16h;
100%
methanesulfonic acid
75-75-2

methanesulfonic acid

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

methyl (S)-pyroglutamate
4931-66-2

methyl (S)-pyroglutamate

Conditions
ConditionsYield
In methanol; chloroform Molecular sieve; Reflux;100%
sodium methylate
124-41-4

sodium methylate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

5-methoxypyrrolidin-2-one

5-methoxypyrrolidin-2-one

Conditions
ConditionsYield
In methanol100%
ethanol
64-17-5

ethanol

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

ethyl (S)-pyroglutamate
7149-65-7

ethyl (S)-pyroglutamate

Conditions
ConditionsYield
With thionyl chloride at 0 - 20℃;99%
With thionyl chloride at 0℃; for 15h;99%
With thionyl chloride at -5 - 20℃; for 10h;98%
L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

Succinimide
123-56-8

Succinimide

Conditions
ConditionsYield
With ammonium peroxydisulfate; silver nitrate In water at 20℃; for 2h; Reagent/catalyst; Temperature;99%
With iodosylbenzene In dichloromethane for 48h; Ambient temperature;27%
allyl alcohol
107-18-6

allyl alcohol

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(S)-allyl 5-oxopyrrolidine-2-carboxylate
4931-79-7

(S)-allyl 5-oxopyrrolidine-2-carboxylate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane99%
With thionyl chloride at 20℃; for 12h;85%
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 5℃; Inert atmosphere;
N1-(4,4-difluorocyclohexyl)-4-(3,5-dimethylisoxazol-4-yl)benzene-1,2-diamine

N1-(4,4-difluorocyclohexyl)-4-(3,5-dimethylisoxazol-4-yl)benzene-1,2-diamine

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(S)-N-(2-((4,4-difluorocyclohexyl)amino)-5-(3,5-dimethylisoxazol-4-yl)phenyl)-5-oxopyrrolidine-2-carboxamide

(S)-N-(2-((4,4-difluorocyclohexyl)amino)-5-(3,5-dimethylisoxazol-4-yl)phenyl)-5-oxopyrrolidine-2-carboxamide

Conditions
ConditionsYield
With triethylamine; HATU In N,N-dimethyl-formamide at 20℃; for 18h;99%
tegaserod
1044642-88-7

tegaserod

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

3-(5-methoxy-1H-indol-3-ylmethylene)-N-pentylcarbazimidamide pidolate

3-(5-methoxy-1H-indol-3-ylmethylene)-N-pentylcarbazimidamide pidolate

Conditions
ConditionsYield
In acetone at 25 - 55℃; for 20h;98.3%
isopropyl alcohol
67-63-0

isopropyl alcohol

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(S)-isopropyl 5-oxopyrrolidine-2-carboxylate
52989-50-1

(S)-isopropyl 5-oxopyrrolidine-2-carboxylate

Conditions
ConditionsYield
With thionyl chloride at 15℃; for 2h;98.1%
With toluene-4-sulfonic acid for 6h; Haller-Bauer Reaction; 4 A molecular sieve;96%
With toluene-4-sulfonic acid for 6h; Heating / reflux;96%
(1S,2R,5S)-(+)-menthol
15356-60-2

(1S,2R,5S)-(+)-menthol

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(S)-[(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl] 2-oxopyrrolidine-5-carboxylate
139014-48-5

(S)-[(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl] 2-oxopyrrolidine-5-carboxylate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane; N,N-dimethyl-formamide at 0 - 23℃; for 24.5h; Inert atmosphere;98%
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 20.5h; Inert atmosphere;86%
carboxymethyl-dodecyl-dimethyl-ammonium betaine
683-10-3

carboxymethyl-dodecyl-dimethyl-ammonium betaine

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

C16H34NO2(1+)*C5H6NO3(1-)

C16H34NO2(1+)*C5H6NO3(1-)

Conditions
ConditionsYield
In ethanol at 25℃; for 0.5h;98%
2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
88150-42-9

2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

amlodipine (R)-(+)-pyroglutamate
663180-17-4

amlodipine (R)-(+)-pyroglutamate

Conditions
ConditionsYield
In ethanol at 5 - 20℃; for 1h;97.1%
L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

LiOH

LiOH

lithium L-pyroglutamate
38609-04-0

lithium L-pyroglutamate

Conditions
ConditionsYield
In water for 2h; Heating;97%
methyl glyoxylate methyl hemi-acetal
109745-70-2, 19757-97-2

methyl glyoxylate methyl hemi-acetal

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

methyl 2-hydroxy-2-(2-oxoprolin-1-yl)acetate
502481-82-5

methyl 2-hydroxy-2-(2-oxoprolin-1-yl)acetate

Conditions
ConditionsYield
In acetone for 60h; Heating;97%
amlodipine
103129-82-4

amlodipine

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(S)-(-)-amlodipine pidolate salt
851447-24-0

(S)-(-)-amlodipine pidolate salt

Conditions
ConditionsYield
In ethanol at 20℃; for 1h;97%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(2S,5R)-6-(sulfoxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
1192500-31-4

(2S,5R)-6-(sulfoxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide

Conditions
ConditionsYield
Stage #1: L-Pyroglutamic acid With benzyl chloride; triethylamine In chloroform at 0℃; for 3.5h; Reflux;
Stage #2: di-tert-butyl dicarbonate With dmap; triethylamine In ethyl acetate at -25 - 35℃; for 4.91667h;
Stage #3: With pyrographite; sodium sulfate In cyclohexane; water Solvent; Temperature;
96.3%
isobutene
115-11-7

isobutene

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

L-t-butyl pyroglutamate
35418-16-7, 85136-12-5

L-t-butyl pyroglutamate

Conditions
ConditionsYield
With sulfuric acid In dichloromethane96%
With sulfuric acid In dichloromethane at 0 - 20℃; Inert atmosphere;78%
With sulfuric acid In dichloromethane at 25℃; for 48h;65%
L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

benzyl alcohol
100-51-6

benzyl alcohol

benzyl (L)-pyroglutamate
94885-52-6

benzyl (L)-pyroglutamate

Conditions
ConditionsYield
With thionyl chloride; N,N-dimethyl-formamide for 15h; Ambient temperature;96%
With thionyl chloride at 0 - 20℃;96%
With thionyl chloride; N,N-dimethyl-formamide at 20℃;90%
(S)-benzyl 2-((S)-2-(2-amino-3-(3-((S)-2-(benzyloxycarbonylamino)-3-tert-butoxy-3-oxopropyl)-2-(triethylsilyl)-1H-indol-6-yl)-4-methylpentanamido)-4-methylpentanamido)-3-methylbutanoate
1189587-53-8

(S)-benzyl 2-((S)-2-(2-amino-3-(3-((S)-2-(benzyloxycarbonylamino)-3-tert-butoxy-3-oxopropyl)-2-(triethylsilyl)-1H-indol-6-yl)-4-methylpentanamido)-4-methylpentanamido)-3-methylbutanoate

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

(S)-benzyl 2-((S)-2-(2-amino-3-(3-((S)-2-(benzyloxycarbonylamino)-3-tert-butoxy-3-oxopropyl)-2-(triethylsilyl)-1H-indol-6-yl)-4-methyl-2-((S)-5-oxopyrrolilidine-2-carboxamido)pentanamido)-4-methylpentanamido)-3-methylbutanoate
1189587-54-9

(S)-benzyl 2-((S)-2-(2-amino-3-(3-((S)-2-(benzyloxycarbonylamino)-3-tert-butoxy-3-oxopropyl)-2-(triethylsilyl)-1H-indol-6-yl)-4-methyl-2-((S)-5-oxopyrrolilidine-2-carboxamido)pentanamido)-4-methylpentanamido)-3-methylbutanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0℃; for 8h;96%
febuxostat

febuxostat

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

febuxostat hemipidolate salt

febuxostat hemipidolate salt

Conditions
ConditionsYield
In acetone at 20 - 25℃; for 4h; Solvent;96%
vortioxetine
508233-74-7

vortioxetine

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine L-pyroglutamate

1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine L-pyroglutamate

Conditions
ConditionsYield
In isopropyl alcohol at 20 - 60℃; for 2h;96%
2-(2-Amino-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester
113994-41-5

2-(2-Amino-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-methyl ester

L-Pyroglutamic acid
98-79-3

L-Pyroglutamic acid

amlodipine (S)-(-)-pyroglutamate

amlodipine (S)-(-)-pyroglutamate

Conditions
ConditionsYield
In ethyl acetate at 25℃; for 1h;95.3%
In ethyl acetate at 25℃; for 1h;95.3%

98-79-3Relevant articles and documents

Identification and characterization of γ-glutamylamine cyclotransferase, an enzyme responsible for γ-glutamyl-ε-lysine catabolism

Oakley, Aaron J.,Coggan, Marjorie,Board, Philip G.

, p. 9642 - 9648 (2010)

γ-Glutamylamine cyclotransferase (GGACT) is an enzyme that converts γ-glutamylamines to free amines and 5-oxoproline. GGACT shows high activity toward γ-glutamyl-ε-lysine, derived from the breakdown of fibrin and other proteins cross-linked by transglutaminases. The enzyme adopts the newly identified cyclotransferase fold, observed in γ- glutamylcyclotransferase (GGCT), an enzyme with activity toward γ-glutamyl-α-amino acids (Oakley, A. J., Yamada, T., Liu, D., Coggan, M., Clark, A. G., and Board, P. G. (2008) J. Biol. Chem. 283, 22031-22042). Despite the absence of significant sequence identity, several residues are conserved in the active sites of GGCTand GGACT, including a putative catalytic acid/base residue (GGACT Glu82). The structure of GGACT in complex with the reaction product 5-oxoproline provides evidence for a commoncatalytic mechanism in both enzymes. The proposed mechanism, combined with the three-dimensional structures, also explains the different substrate specificities of these enzymes. Despite significant sequence divergence, there are at least three subfamilies in prokaryotes and eukaryotes that have conserved the GGCT fold and GGCT enzymatic activity.

Crystal structure and functional analysis of the glutaminyl cyclase from Xanthomonas campestris

Huang, Wei-Lin,Wang, Yu-Ruei,Ko, Tzu-Ping,Chia, Cho-Yun,Huang, Kai-Fa,Wang, Andrew H.-J.

, p. 374 - 388 (2010)

Glutaminyl cyclases (QCs) (EC 2.3.2.5) catalyze the formation of pyroglutamate (pGlu) at the N-terminus of many proteins and peptides, a critical step for the maturation of these bioactive molecules. Proteins having QC activity have been identified in animals and plants, but not in bacteria. Here, we report the first bacterial QC from the plant pathogen Xanthomonas campestris (Xc). The crystal structure of the enzyme was solved and refined to 1.44-A resolution. The structure shows a β-propeller and exhibits a scaffold similar to that of papaya QC (pQC), but with some sequence deletions and conformational changes. In contrast to the pQC structure, the active site of XcQC has a wider substrate-binding pocket, but its accessibility is modulated by a protruding loop acting as a flap. Enzyme activity analyses showed that the wild-type XcQC possesses only 3% QC activity compared to that of pQC. Superposition of those two structures revealed that an active-site glutamine residue in pQC is substituted by a glutamate (Glu45) in XcQC, although position 45 is a glutamine in most bacterial QC sequences. The E45Q mutation increased the QC activity by an order of magnitude, but the mutation E45A led to a drop in the enzyme activity, indicating the critical catalytic role of this residue. Further mutagenesis studies support the catalytic role of Glu89 as proposed previously and confirm the importance of several conserved amino acids around the substrate-binding pocket. XcQC was shown to be weakly resistant to guanidine hydrochloride, extreme pH, and heat denaturations, in contrast to the extremely high stability of pQC, despite their similar scaffold. On the basis of structure comparison, the low stability of XcQC may be attributed to the absence of both a disulfide linkage and some hydrogen bonds in the closure of β-propeller structure. These results significantly improve our understanding of the catalytic mechanism and extreme stability of type I QCs, which will be useful in further applications of QC enzymes.

A colorimetric assay method for measuring D-glutamate cyclase activity

Ariyoshi, Makoto,Hamase, Kenji,Homma, Hiroshi,Katane, Masumi,Matoba, Satoaki,Mita, Masashi,Miyamoto, Tetsuya,Motoda, Risa,Nakayama, Kazuki,Saitoh, Yasuaki,Sakai-Kato, Kumiko,Sekine, Masae,Tateishi, Shuhei

, (2020/07/31)

In mammals, metabolism of free D-glutamate is regulated by D-glutamate cyclase (DGLUCY), which reversibly converts D-glutamate to 5-oxo-D-proline and H2O. Metabolism of these D-amino acids by DGLUCY is thought to regulate cardiac function. In this study, we established a simple, accurate, and sensitive colorimetric assay method for measuring DGLUCY activity. To this end, we optimized experimental procedures for derivatizing 5-oxo-D-proline with 2-nitrophenylhydrazine hydrochloride. 5-Oxo-D-proline was derivatized with 2-nitrophenylhydrazine hydrochloride in the presence of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide as a catalyst to generate the acid hydrazides, whose levels were then determined using a colorimetric method. Under optimized conditions, we examined the sensitivity and accuracy of the colorimetric method and compared our technique with other methods by high-performance liquid chromatography with ultraviolet–visible or fluorescence detection. Moreover, we assessed the suitability of this colorimetric method for measuring DGLUCY activity in biological samples. Our colorimetric method could determine DGLUCY activity with adequate validity and reliability. This method will help to elucidate the relationship among DGLUCY activity, the physiological and pathological roles of D-glutamate and 5-oxo-D-proline, and cardiac function.

Organocatalytic Decarboxylation of Amino Acids as a Route to Bio-based Amines and Amides

Claes, Laurens,Janssen, Michiel,De Vos, Dirk E.

, p. 4297 - 4306 (2019/08/26)

Amino acids obtained by fermentation or recovered from protein waste hydrolysates represent an excellent renewable resource for the production of bio-based chemicals. In an attempt to recycle both carbon and nitrogen, we report here on a chemocatalytic, metal-free approach for decarboxylation of amino acids, thereby providing a direct access to primary amines. In the presence of a carbonyl compound the amino acid is temporarily trapped into a Schiff base, from which the elimination of CO2 may proceed more easily. After evaluating different types of aldehydes and ketones on their activity at low catalyst loadings (≤5 mol%), isophorone was identified as powerful organocatalyst under mild conditions. After optimisation many amino acids with a neutral side chain were converted in 28–99 % yield in 2-propanol at 150 °C. When the reaction is performed in DMF, the amine is susceptible to N-formylation. This consecutive reaction is catalysed by the acidity of the amino acid reactant itself. In this way, many amino acids were efficiently transformed to the corresponding formamides in a one-pot catalytic system.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 98-79-3